Share:
Peer-Reviewed Publication
J Clin Med2021;10(4)February 5, 2021Journal Article

The Effect of a Comprehensive, Interdisciplinary Medication Review on Quality of Life and Medication Use in Community Dwelling Older People with Polypharmacy.

Donna Bosch-Lenders1, Jesse Jansen1, Henri E J H Jelle Stoffers1, Bjorn Winkens2, Karin Aretz3, Mascha Twellaar1, Jos M G A Schols4, Paul-Hugo M van der Kuy5, J André Knottnerus1, Marjan van den Akker1,6,7
1Department of Family Medicine, Care and Public Health Research Institute (CAHPRI), Maastricht University, 6200 MD Maastricht, The Netherlands.
2Department of Methodology and Statistics, Care and Public Health Research Institute (CAHPRI), Maastricht University, 6200 MD Maastricht, The Netherlands.
3MEMIC, Center for Data and Information Management, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200 MD Maastricht, The Netherlands.
4Department of Health Services Research, Care and Public Health Research Institute (CAHPRI), Maastricht University, 6200 MD Maastricht, The Netherlands.
5Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
6Institute of General Practice, Goethe University, 60590 Frankfurt am Main, Germany.
7Academic Centre of General Practice, Department of Public Health and Primary Care, KU Leuven, 3000 Leuven, Belgium.

Abstract

Background: We conducted a comprehensive medication review at the patients' home, using data from electronic patient records, and with input from relevant specialists, general practitioners and pharmacists formulated and implemented recommendations to optimize medication use in patients aged 60+ years with polypharmacy. We evaluated the effect of this medication review on quality of life (QoL) and…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.